Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
Clinical trial NCT04493853 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04493853
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2024-10-07
- Enrollment
- 1012
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.